Stereotactic Radiosurgery Technology

Julie, Diana; Knisely, Jonathan

doi:10.1007/978-3-030-42958-4_21

Cited by 1 publication

(1 citation statement)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Stereotactic radiosurgery (SRS) is an interdisciplinary procedure that involves the use of high-resolution anatomical images and specialized equipment supported by high-definition stereoscopic images, combining the principles of stereotaxy with intense focal radiation techniques. The aim of SRS is to localize the irradiation to the tumor tissue while preserving healthy cells [ 1 ]. This technique is provided in a single session.…”

Section: Introductionmentioning

confidence: 99%

Treatment of Intracranial Tumors With Stereotactic Radiosurgery: Short-Term Results From Cuba

Aquino¹,

Ramirez²,

Bozkurt³

et al. 2022

Cureus

View full text Add to dashboard Cite

BackgroundAlthough international publications on radiosurgery have increased exponentially, reports of heterogeneous series treated with linear accelerator (LINAC) are scarce. Since most intracranial tumors are irregular in size and not spherical, LINACs (Elekta Precise®, Elekta AB, Sweden), fitted with a multi-leaf collimator, allow for precise stereotactic radiosurgery for the entire tumor. AimTo evaluate the effects of LINAC on an outpatient basis with patients diagnosed with various intracranial malignancies. MethodologyA retrospective observational study of a series of cases of patients with intracranial lesions treated at the Institute of Oncology and Radiobiology using LINAC was carried out from October 2019 to May 2021 to evaluate the therapeutic results of radiosurgery in patients with intracranial tumors. ResultsA total of 22 lesions in 20 patients were treated with LINAC. The average age of the patients was 49.7, and the male-female ratio was 1:2. The cases consisted were mostly vestibular schwannoma (7 lesions), metastases from breast cancer (3 lesions), and tuberculum sellae meningioma (2 lesions). The prescription dose covered 99% of the planning target volume in 16 lesions (72.7%) and 100% in six lesions (27.3%) (prescription volume). In meningiomas and schwannomas, doses between 12 and 14 Gy were used, in plasmacytoma 13 Gy, in pilocytic astrocytoma 14 Gy, in cavernoma 15 Gy, in breast cancer metastasis between 18 and 20 Gy, and in lung cancer metastasis 22 Gy. When evaluating local control, 11 patients exhibited stable findings at the six-month control while 10 had partial regression, and a single patient had total regression. Minor complications such as perilesional edema, facial paresthesia, facial paralysis, and transient alopecia were observed in eight of the patients. ConclusionsPatients with extra-axial, low-grade malignancy, and posterior fossa lesions were predominant in the studied population. Radiosurgery treatment is associated with good local control of the treated lesions. Complications are infrequent, mild, and predominated by perilesional edema.

show abstract

Section: Introductionmentioning

confidence: 99%